Childhood leptospirosis in an industrialized country: Population-based study in Okinawa, Japan
- PMID: 29518084
- PMCID: PMC5860792
- DOI: 10.1371/journal.pntd.0006294
Childhood leptospirosis in an industrialized country: Population-based study in Okinawa, Japan
Abstract
Leptospirosis is considered underdiagnosed because of its nonspecific presentation and lack of proper understanding of its epidemiology. Early diagnosis and treatment are crucial. However, few data are available on confirmed leptospirosis cases in children in industrialized countries. We therefore aimed to describe epidemiologic and clinical characteristics of laboratory-confirmed childhood leptospirosis in Okinawa, Japan. We reviewed the national surveillance data of pediatric leptospirosis in Okinawa, Japan from January 2003 through December 2015. The database included all of laboratory-confirmed leptospirosis diagnosed at the only central laboratory for leptospirosis in the region. There were 44 children (0-20 years of age) with laboratory-confirmed leptospirosis. Of these, 90% were male, 91% were 10-20 years of age, and 96% of cases occurred in August and September. The number of laboratory-confirmed patients ranged from 0 to 11 per year (mean: 3.3 per year), and the estimated annual rate was 1.0 per 100,000 pediatric populations. In all cases, the presumed infection route was recreational exposure to river water. Commonly observed manifestations include fever (95%), myalgia (52%), and conjunctival suffusion (52%). Childhood leptospirosis in Okinawa, Japan occurred predominantly in teenage boys after freshwater exposure in summer, and most patients had characteristic conjunctival suffusion. Cohort studies would be helpful to better understand more detailed clinical manifestations in association with prognosis.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Tullu MS, Karande S. Leptospirosis in children: a review for family physicians. Indian J Med Sci. 2009;63(8):368–78. doi: 10.4103/0019-5359.55893 - DOI - PubMed
-
- Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Roanoa CP, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet. 1988:1(8583):433–5. - PubMed
-
- Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3(12):757–71. - PubMed
-
- Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis. 2001;33(11):1834–41. doi: 10.1086/324084 - DOI - PubMed
-
- Dutta TK, Christopher M. Leptospirosis—an overview. J Assoc Physicians India. 2005; 53:545–51. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
